[31-501-am] Pharmacotherapies (Personalized therapies)/Risk management

Sun. Mar 31, 2024 8:30 AM - 9:06 AM [Room 501] Conference Center 501 (5F)

Chair: Kurono Shunsuke, Takehiro Kawashiri

+Add all to schedule

8:30 AM - 8:42 AM

[31-501-am01] The best diabetes drug treatment for individuals -Focusing on new diabetes drugs-

○Setsuko Tomioka¹, Naoki Yamazaki² (1. Iryo Sosei University Faculty of Nursing, 2. Iryo Sosei University Faculty of Pharmacy)

8:42 AM - 8:54 AM

[31-501-am02S] Impact of NUDT15 polymorphism on valganciclovir prophylaxis completion in lung transplant recipients

○Yuzuki Urabe^1,2, Yurie Katsube², Keisuke Umemura², Miori Ono², Yoshiki Katada^2,3, Daiki Hira², Masahiro Tsuda^1,2, Shunsaku Nakagawa², Akihiro Ohsumi⁴, Daisuke Nakajima⁴, Miki Nagao³, Hiroshi Date⁴, Tomohiro Terada² (1. Grad. Sch. Pharm. Sci., Kyoto Univ., 2. Dept. Clin. Pharmacol. Ther., Kyoto Univ. Hosp., 3. Dept. Infect. Cont. Prev., Kyoto Univ. Hosp., 4. Dept. Thorac. Surg., Kyoto Univ. Hosp.)

8:54 AM - 9:06 AM

[31-501-am03S] Analysis of Parkinson's Disease by Data-Driven Long-Term Disease Progression Modeling Using Neural Networks

○Ryota Jin¹, Hiromi Sato¹, Akihiro Hisaka¹ (1. Grad. Sch. Pharm. Sci., Chiba Univ.)